Chinese startup Infervision emerges from stealth with an AI tool for diagnosing lung cancer

Roughly 600,000 people in China die from lung cancer every year. The issue is compounded by a lack of quality healthcare in much of the country, which means that cancers often go undetected until it’s too late. Enter Infervision, a Beijing-based company using machine learning and computer vision to help diagnose cancers.